<code id='A49E5F06BB'></code><style id='A49E5F06BB'></style>
    • <acronym id='A49E5F06BB'></acronym>
      <center id='A49E5F06BB'><center id='A49E5F06BB'><tfoot id='A49E5F06BB'></tfoot></center><abbr id='A49E5F06BB'><dir id='A49E5F06BB'><tfoot id='A49E5F06BB'></tfoot><noframes id='A49E5F06BB'>

    • <optgroup id='A49E5F06BB'><strike id='A49E5F06BB'><sup id='A49E5F06BB'></sup></strike><code id='A49E5F06BB'></code></optgroup>
        1. <b id='A49E5F06BB'><label id='A49E5F06BB'><select id='A49E5F06BB'><dt id='A49E5F06BB'><span id='A49E5F06BB'></span></dt></select></label></b><u id='A49E5F06BB'></u>
          <i id='A49E5F06BB'><strike id='A49E5F06BB'><tt id='A49E5F06BB'><pre id='A49E5F06BB'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:27
          close-up of psoriasis on a hand. -- biotech coverage from STAT
          A close-up of psoriasis on a hand. Adobe

          San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

          Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

          advertisement

          Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Young boy dies in trial for Pfizer Duchenne gene therapy
          Young boy dies in trial for Pfizer Duchenne gene therapy

          MarkLennihan/APAyoungboydiedinatrialforPfizer’sexperimentalgenetherapyforDuchennemusculardystrophy,t

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

          6:54Rep.ByronDonaldsspeaksduringanewsconferenceonMarch10,2023inWashington,D.C.AnnaMoneymaker/GettyIm